Brigham and Women's Hospital / Dana Farber Cancer Institute — Boston, Massachusetts

Brigham and Women's Hospital / Dana Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02446.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Brigham and Women's Hospital / Dana Farber Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Retroperitoneal Sarcoma.

Sponsors: Brigham and Women's Hospital.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Brigham and Women's Hospital / Dana Farber Cancer Institute?

Brigham and Women's Hospital / Dana Farber Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Brigham and Women's Hospital / Dana Farber Cancer Institute conducted?

Brigham and Women's Hospital / Dana Farber Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Retroperitoneal Sarcoma.

Is Brigham and Women's Hospital / Dana Farber Cancer Institute accredited by Crixeo Health?

Brigham and Women's Hospital / Dana Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Brigham and Women's Hospital / Dana Farber Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.